About Henry Schein Inc
Ticker
info
HSIC
Trading on
info
NASDAQ
ISIN
info
US8064071025
Industry
info
Medical Distribution
Sector
info
Healthcare
CEO
info
-
Headquarters
info
135 Duryea Road, Melville, NY, United States, 11747
Employees
info
25,000
Website
info
henryschein.com
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Metrics
BasicAdvanced
Market cap
info
$9.48B
P/E ratio
info
25.31
EPS
info
$3.36
Dividend Yield
info
0.00%
Beta
info
0.81
Forward P/E ratio
info
14.71
EBIDTA
info
$1.08B
Ex dividend date
info
-
Price & volume
Market cap
info
$9.48B
Average daily volume
info
1M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
25.31
Forward P/E
info
14.71
PEG ratio
info
1.73
Trailing P/E
info
25.31
Price to sales
info
0.71
Price to book
info
3.06
Earnings
EPS
info
$3.36
EPS estimate (current quarter)
info
$1.24
EPS estimate (next quarter)
info
$1.36
EBITDA
info
$1.08B
Revenues (TTM)
info
$13.6B
Revenues per share (TTM)
info
$116.77
Technicals
Beta
info
0.81
52-week High
info
$92.18
52-week Low
info
$61.95
50-day moving average
info
$87.81
200-day moving average
info
$79.60
Short ratio
info
7.04
Short %
info
8.85%
Management effectiveness
ROE (TTM)
info
8.85%
ROA (TTM)
info
4.39%
Profit margin
info
2.96%
Gross profit margin
info
$4.26B
Operating margin
info
5.76%
Growth
Quarterly earnings growth (YoY)
info
17.10%
Quarterly revenue growth (YoY)
info
6.70%
Share stats
Outstanding Shares
info
111M
Float
info
91.7M
Insiders %
info
0.83%
Institutions %
info
112.26%
Analyst Insights & forecasts
info

44% Buy

50% Hold

6% Sell

Based on information from 16 analysts.

Average price target

info
$98.19
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$1.38
$1.28
7.81%
Q3 • 25Beat
$1.34
$1.30
3.08%
Q4 • 25Beat
$1.32
$1.22
8.20%
Q1 • 26Beat
$1.27
$1.22
4.10%
Q2 • 26Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$3.37B
$107M
3.18%
Q1 • 26
$3.46B
$94M
2.72%
Q2 • 26
2.67%
-12.15%
-14.44%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$11.3B
$6.48B
57.34%
Q1 • 26
$11.4B
$6.66B
58.50%
Q2 • 26
0.68%
2.72%
2.02%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-97M
-
$120M
$-136M
Q1 • 26
$242M
-
$-168M
$196M
Q2 • 26
-349.48%
-
-240.00%
-244.12%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Henry Schein Inc share?
Collapse

Henry Schein Inc shares are currently traded for undefined per share.

How many shares does Henry Schein Inc have?
Collapse

Henry Schein Inc currently has 111M shares.

Does Henry Schein Inc pay dividends?
Collapse

No, Henry Schein Inc doesn't pay dividends.

What is Henry Schein Inc 52 week high?
Collapse

Henry Schein Inc 52 week high is $92.18.

What is Henry Schein Inc 52 week low?
Collapse

Henry Schein Inc 52 week low is $61.95.

What is the 200-day moving average of Henry Schein Inc?
Collapse

Henry Schein Inc 200-day moving average is $79.60.

Who is Henry Schein Inc CEO?
Collapse

The CEO of Henry Schein Inc is -.

How many employees Henry Schein Inc has?
Collapse

Henry Schein Inc has 25,000 employees.

What is the market cap of Henry Schein Inc?
Collapse

The market cap of Henry Schein Inc is $9.48B.

What is the P/E of Henry Schein Inc?
Collapse

The current P/E of Henry Schein Inc is 25.31.

What is the EPS of Henry Schein Inc?
Collapse

The EPS of Henry Schein Inc is $3.36.

What is the PEG Ratio of Henry Schein Inc?
Collapse

The PEG Ratio of Henry Schein Inc is 1.73.

What do analysts say about Henry Schein Inc?
Collapse

According to the analysts Henry Schein Inc is considered a hold.